Author: Talia Ogliore

A new study led by WashU Medicine researchers shows that, for blood cancer patients, a genetically engineered stem cell transplant helps prevent toxic side effects and potentially improves the effectiveness of therapies.

Six WashU seniors from the Department of BIology in Arts & Sciences and WashU McKelvey Engineering have won annual awards recognizing their achievements.

A WashU Medicine-led clinical trial has found that a personalized vaccine to treat glioblastoma appears to increase recurrence-free survival in a subset of patients after surgery.

WashU Medicine researchers at the Bright Center for Human Vision have developed gene therapies that help retinal cells clear toxic proteins in mouse and human models of retinitis pigmentosa, an inherited degenerative condition that causes blindness.

WashU Medicine researchers discovered a cellular mechanism that may protect some patients with a genetic lung condition from developing liver damage.

Salma Abdalla, at WashU Public Health, and Liz Chiarello, in WashU Arts & Sciences, have been named 2026 Public Scholarship faculty fellows in recognition of their work that connects rigorous research with public audiences.

A grant of nearly $800,000 will fund the development of an “AI Scientist” system aimed at improving biomedical research efficiency, with an initial focus on neurodegenerative disease.

Monica Chang-Panesso, MD, and Hysell Oviedo, PhD, were recognized for their research on kidney repair and the brain’s processing of sound and speech, respectively.

Arts & Sciences honored seven alumni for their achievements, service and commitment to the liberal arts.

Three physician-scientists at WashU Medicine — neurologists Suzanne Schindler and Christopher Smyser and otolaryngologist Sidharth Puram — have been recognized by one of the nation’s oldest and most respected medical honor societies.